Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
JAMA Ophthalmology Author Interviews9 Jan 2012

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
jss
sinnsyn
rss-rekommandert
liberal-halvtime
forskningno
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-nysgjerrige-norge
villmarksliv
kvinnehelsepodden
nordnorsk-historie
rss-paradigmepodden
smart-forklart
vett-og-vitenskap-med-gaute-einevoll
nevropodden
hva-er-greia-med
aldring-og-helse-podden